#news #medical #clinicalresearch #lifesciences #pharma #pharmiweb
Cheminformatics, Medicinal chemistry, Medicine, World Health Organization, Pharmacology, Infectious disease
ZebiAI and TB Alliance Announce Collaboration to Apply ML-Driven Discovery Platform to Tuberculosis Targets
ZebiAI and TB Alliance Announce Collaboration to Apply ML-Driven Discovery Platform to Tuberculosis Targets
https://t.co/dFY8Z53vPX
#news #pharma #clinicalresearch #biotech #lifesciences #medical #healthcare #pharmiweb https://t.co/6iFCRfk3OV
OpenTB Alliance to leverage ZebiAI’s platform to discover novel probe compounds for important tuberculosis targets, with options for drug discoveryWALTHAM, Mass.--(BUSINESS WIRE)--ZebiAI, Inc., a biotech company focused on improving human health by powering machine learning (ML) to source ...
ZebiAI and TB Alliance Announce Collaboration to Apply ML-Driven Discovery Platform to Tuberculosis Targets
https://t.co/dFY8Z53vPX
#news #pharma #clinicalresearch #biotech #lifesciences #medical #healthcare #pharmiweb https://t.co/6iFCRfk3OV
OpenZebiAI and TB Alliance Announce Collaboration to Apply ML-Driven Discovery Platform to Tuberculosis Targets
TB Alliance to leverage ZebiAI’s platform to discover novel probe compounds for important tuberculosis targets, with options for drug discoveryWALTHAM, Mass.--(BUSINESS WIRE)--ZebiAI, Inc., ...
We are sorry, we could not find the related article
If you are curious about Biotech Essentials, the Influencers Review and Career and Jobs
Please click on:
Or signup to our newsletters
Other Essentials
AI Essentials
Robotics
Robotics
Ethics
Ethics
Research
Research
Applied Use Cases
Applied Use Cases
Marketing
Marketing
Healthcare
Healthcare
Cybersecurity
Cybersecurity
Africa: TB Alliance Announces European Commission Authorisation of New Treatment for Highly Drug-Resistant Tuberculosis
Press Release - PRETORIA (3 August 2020)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, has been granted a conditional marketing authorisation by the ...
Unlocking the power of machine learning for small molecule drug discovery
Rick Wagner of ZebiAI and Patrick Riley of GAS discuss the development and benefits of a new machine learning drug discovery platform.
Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for Fibrotic Diseases
- Drug discovery partnership and equity investment led by Leaps by Bayer in Series D financing round - Digitally-powered drug discovery to address fibrotic diseases with previously ...
Why We’re Still Fighting One of the World’s Most Ancient Diseases
Tuberculosis (TB) may be an ancient disease, but it is still the leading cause of infectious death worldwide, affecting more than 10 million people and killing 1.6 million in 2017 alone. ...
First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis
· A new global collaboration of philanthropic, non-profit and private sector organizations will work together to accelerate the development of novel TB treatment regimens for all TB ...
Pharma’s AlphaGo Moment: For the First Time AI Has Designed and Validated a New Drug Candidate in Days
Insilico Medicine has succeeded in using AI to design a new molecule from scratch in 21 days and validate it in 25 days. This is the first time that the true transformative and disruptive ...
Report: TB Could Be Conquered by 2045
It's within the world's means to end ancient scourge
AI Approach Identifies Potential New Drugs to Treat COVID-19
Machine learning drug discovery pipeline to identify hundreds of new potential drugs that could help treat COVID-19. copyright by www.genengnews.com There is an …
Atomwise Receives a $2.3M Grant to Develop New Therapies for Drug Resistant Malaria and Tuberculosis
The $2.3M in grant funding from the Bill & Melinda Gates Foundation will support the development of multiple global health programs to advance novel antimalarial and anti-tuberculosis small ...
Designing new drugs takes years, but A.I. could help reduce that to days
A new biotech company called Insilico Medicine is using advanced artificial intelligence algorithms to potentially discover the next world-changing drugs. Here's what it's demonstrated so ...